In vitro microbiological evaluation of piperidino 2-thioxoimidazolidin-4-ones
69
J
J
2a,3e = 3.08 Hz, J2a,3a = 11.76 Hz), 4.15–4.19 (dd, 1H, H6a,
6a,5e = 3.2 Hz, J6a,5a = 11.88 Hz), 7.23–7.5 (m, 10H, Ar-H’s),
3-(2,6-dip-tolylpiperidin-4-ylideneamino)-2-
thioxoimidazolidin-4-one 35
11.78 (s, NH of imidazolidine); In the D2O exchanged 1H
NMR spectrum, two peaks at 2.83 ppm and 11.78 ppm
which resonances due to NH of piperidine and imidazo-
lidine respectively disappeared; 13C NMR (δ ppm): 29.6
C-3, 37.3 C-5, 43.6 CH2 of imidazolidine, 60.2 C-2, 61.1
C-6, 126.5–128.1 Ar-C’s, 144, 144.1 ipso-C, 163.1 C=N,
167.6 C=O, 173.8 C=S.
Irradiation reaction time = 3 min; IR (KBr) (cm−1): 3403,
3308, 3063, 3018, 2960, 2921, 2850, 1727, 1631, 1600, 1249,
1
1023, 828, 742, 524; H NMR (δ ppm): 1.97–2.05 (m, 1H,
H3a), 2.18 (s, 6H, CH3 at the phenyl rings), 2.34–2.38 (dd,
1H, H3e, J3e,3a = 13.5 Hz, J3e,2a = 2.97 Hz); 2.45–2.52 (m, 1H,
H5a), 2.84 (s, 1H, NH of piperidine), 3.49–3.52 (dd, 1H, H5e,
J5e,5a = 3.14 Hz, J5e,6a = 13.42 Hz), 3.76 (s, 2H, CH2 of imida-
zolidine), 3.88–3.9 (dd, 1H, H2a, J2a,3e = 3.14 Hz, J2a,3a = 11.66
Hz), 4.14–4.18 (dd, 1H, H6a, J6a,5e = 3.07 Hz, J6a,5a = 11.66 Hz),
7.17–7.39 (m, 8H, Ar-H’s), 11.76 (s, 1H, NH of imidazoli-
dine); 13C NMR (δ ppm): 22.2 -CH3 at the phenyl rings,
30.3 C-3, 37.2 C-5, 43.3 CH2 of imidazolidine, 60.1 C-2, 61
C-6, 127.1–143.9 Ar-C’s, 144.1, 147.2, ipso-C, 162.8 C=N,
167.5 C=O, 173.5 C=S.
3-(2,6-bis(4-fluorophenyl)piperidin-4-ylideneamino)-2-
thioxoimidazolidin-4-one 32
Irradiation reaction time = 4 min; IR (KBr) (cm−1): 3430,
3317, 3076, 3030, 2956, 2924, 2854, 1717, 1641, 1604, 1092,
1
835, 733, 519; H NMR (δ ppm): 1.98–2.05 (m, 1H, H3a),
2.39–2.44 (dd, 1H, H3e, J3e,3a = 13.52 Hz, J3e,2a = 2.96 Hz);
2.44–2.49 (m, 1H, H5a), 2.86 (s, 1H, NH of piperidine),
3.51–3.55 (dd, 1H, H5e, J5e,5a = 2.96 Hz, J5e,6a = 13.4 Hz),
3.77 (s, 2H, CH2 of imidazolidine), 3.85–3.89 (dd, 1H,
H2a, J2a,3e = 2.96 Hz, J2a,3a = 11.76 Hz), 4.16–4.2 (dd, 1H, H6a,
3-(3-methyl-2,6-diphenylpiperidin-4-ylideneamino)-2-
thioxoimidazolidin-4-one 36
Irradiation reaction time=2min; IR (KBr) (cm−1): 3420,
3311, 3063, 3031, 2978, 2933, 1713, 1634, 1600, 1232,
J
6a,5e = 3.32 Hz, J6a,5a = 11.96 Hz), 7.18–7.37 (m, 8H, Ar-H’s),
11.81 (s, 1H, NH of imidazolidine); 13C NMR (δ ppm):
30.1 C-3, 38.2 C-5, 43.4 CH2 of imidazolidine, 61.8 C-2,
62.9 C-6, 114.3–142.6 Ar-Cs, 142.9, 159.6 ipso-C, 162 C=N,
166.7 C=O, 173.7 C=S.
1
755, 702; H NMR (δ ppm): 0.77–0.79 (d, 3H, CH3 at C-3,
JCH3,3a =6.45 Hz), 2.05–2.11 (m, 1H, H5a), 2.55–2.59 (m, 1H,
H3a), the signal for 1H, NH of piperidine merged with water
peak,2.69–2.79(m,1H,H5e),3.45–3.48(d,1H,H2a,J2a,3a =9.98
Hz), 3.54–3.58 (dd, 1H, H6a, J6a,5e =2.5 Hz, J6a,5a =12.95 Hz),
3.76 (s, 2H, CH2 of imidazolidine), 7.24–7.47 (m, 10H,
Ar-H’s), 11.71 (s, NH of imidazolidine); 13C NMR (δ ppm):
11.9 -CH3 at C-3, 32.5 C-5, 37.3 C-3, 44.4 CH2 of imidazo-
lidine, 60.4 C-6, 68.7 C-2, 126.5–128.1 Ar-C’s, 144.9, 144,
ipso-C, 163.1 C=N, 167.5 C=O, 173.8 C=S.
3-(2,6-bis(4-chlorophenyl)piperidin-4-ylideneamino)-2-
thioxoimidazolidin-4-one 33
Irradiation reaction time = 4 min; IR (KBr) (cm−1): 3400,
3309, 3065, 3032, 2978, 2923, 2852, 1724, 1628, 1595, 1195,
1
1014, 826, 722, 676, 634; H NMR (δ ppm): 1.98–2.05 (m,
1H, H3a), 2.38–2.42 (dd, 1H, H3e, J3e,3a = 13.52 Hz, J3e,2a = 2.98
Hz); 2.43–2.48 (m, 1H, H5a), 2.79 (s, 1H, NH of piperi-
dine), 3.52–3.56 (dd, 1H, H5e, J5e,5a = 3.08 Hz, J5e,6a = 13.42
Hz), 3.78 (s, 2H, CH2 of imidazolidine), 3.87–3.91 (dd, 1H,
H2a, J2a,3e = 3.08 Hz, J2a,3a = 11.76 Hz), 4.15–4.19 (dd, 1H, H6a,
3-(2,6-bis(4-fluorophenyl)-3-methylpiperidin-4-
ylideneamino)-2-thioxoimidazolidin-4-one 37
Irradiation reaction time = 3 min; IR (KBr) (cm−1):
3412, 3304, 3071, 3030, 2985, 2931, 2869, 1717, 1635,
1597, 1221, 1030, 535, 836, 766; 1H NMR (δ ppm):
0.78–0.8 (d, 3H, CH3 at C-3, JCH3,3a = 6.58 Hz), 2.07–2.09
(m, 1H, H5a), 2.54–2.59 (m, 1H, H3a), the signal for 1H,
NH of piperidine merged with water peak, 2.67–2.79
(m, 1H, H5e), 3.46–3.48 (d, 1H, H2a, J2a,3a = 10.61 Hz),
J6a,5e = 3.14 Hz, J6a,5a = 11.70 Hz), 7.3–7.58 (m, 8H, Ar-H’s),
11.79 (s, 1H, NH of imidazolidine); 13C NMR (δ ppm): 30
C-3, 38.8 C-5, 43.5 CH2 of imidazolidine, 60.9 C-2, 61.2
C-6, 126.7–140.4 Ar-C’s, 144.7, 145.3 ipso-C, 163.1 C=N,
166.8 C=O, 173.5 C=S.
3.54–3.58 (dd, 1H, H6a,
J6a,5e = 2.46 Hz, J6a,5a = 12.46
3-(2,6-bis(4-methoxyphenyl)piperidin-4-ylideneamino)-2-
thioxoimidazolidin-4-one 34
Hz), 3.78 (s, 2H, CH2 of imidazolidine), 7.12–7.51 (m,
8H, Ar-H’s), 11.72 (s, NH of imidazolidine); 13C NMR
(δ ppm): 11.8 -CH3 at C-3, 32.5 C-5, 37.2 C-3, 44.5 CH2
of imidazolidine, 61 C-6, 67.7 C-2, 114.6–160.7 Ar-C’s,
162.4, 162.5, ipso-C, 163.4 C=N, 169.2 C=O, 173.9 C=S.
Irradiation reaction time = 3 min; IR (KBr) (cm−1): 3400,
3306, 3065, 3020, 2962, 2924, 2853, 1728, 1630, 1601,
1251, 1031, 830, 749, 527; 1H NMR (δ ppm): 1.97–2.04 (m,
1H, H3a), 2.35–2.39 (dd, 1H, H3e, J3e,3a = 13.52 Hz, J3e,2a = 2.96
Hz); 2.43–2.5 (m, 1H, H5a), 2.89 (s, 1H, NH of piperidine),
3.48–3.53 (dd, 1H, H5e, J5e,5a = 3.16 Hz, J5e,6a = 13.4 Hz),
3.59 (s, 6H, OCH3 at the phenyl rings), 3.72 (s, 2H, CH2
of imidazolidine), 3.87–3.91 (dd, 1H, H2a, J2a,3e = 3.16 Hz,
3-(2,6-bis(4-chlorophenyl)-3-methylpiperidin-4-
ylideneamino)-2-thioxoimidazolidin-4-one 38
Irradiation reaction time = 4 min; IR (KBr) (cm−1): 3429,
3282, 3070, 3032, 2985, 2931, 1718, 1625, 1592, 1210,
1
J
J
2a,3a = 11.68 Hz), 4.13–4.17 (dd, 1H, H6a, J6a,5e = 3.08 Hz,
6a,5a = 11.68 Hz), 7.19–7.42 (m, 8H, Ar-H’s), 11.78 (s, 1H,
1017, 897, 823; H NMR (δ ppm): 0.77–0.79 (d, 3H, CH3
at C-3, JCH3,3a = 6.57 Hz), 2.01–2.07 (m, 1H, H5a), 2.53–2.57
(m, 1H, H3a), the signal for 1H, NH of piperidine merged
with water peak, 2.68–2.8 (m, 1H, H5e), 3.46–3.48 (d, 1H,
H2a, J2a,3a = 10.82 Hz), 3.54–3.58 (dd, 1H, H6a, J6a,5e = 2.44
Hz, J6a,5a = 12.45 Hz), 3.9 (s, 2H, CH2 of imidazolidine),
NH of imidazolidine); 13C NMR (δ ppm): 30.1 C-3, 37
C-5, 43.1 CH2 of imidazolidine, 54.2 -OCH3 at the phenyl
rings, 60.2 C-2, 61.1 C-6, 127.3–144.0 Ar-C’s, 144.1, 159.9,
ipso-C, 162.3 C=N, 167.7 C=O, 173.8 C=S.
© 2011 Informa UK, Ltd.